Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M22,477Revenue $M8,054Net Margin (%)16.1Z-Score4.6
Enterprise Value $M23,811EPS $6.5Operating Margin %15.6F-Score6
P/E(ttm))23.7Cash Flow Per Share $8.2Pre-tax Margin (%)14.5Higher ROA y-yN
Price/Book4.210-y EBITDA Growth Rate %9.5Quick Ratio2.2Cash flow > EarningsY
Price/Sales2.75-y EBITDA Growth Rate %3.3Current Ratio2.9Lower Leverage y-yY
Price/Cash Flow9.5y-y EBITDA Growth Rate %-10.7ROA % (ttm)10.6Higher Current Ratio y-yN
Dividend Yield %1.8Insider Buy (3m)0ROE % (ttm)25.6Less Shares Outstanding y-yY
Payout Ratio %42.0Shares Outstanding M193ROI % (ttm)16.2Gross Margin Increase y-yN

Gurus Latest Trades with BDX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BDXJohn Hussman 2014-06-30 Add0.69%$111.18 - $120.33
($116.18)
$ 117.171%Add 75%175,000
BDXJean-Marie Eveillard 2014-06-30 Buy 0.17%$111.18 - $120.33
($116.18)
$ 117.171%New holding, 582656 sh.582,656
BDXJoel Greenblatt 2014-06-30 Buy 0.12%$111.18 - $120.33
($116.18)
$ 117.171%New holding, 80303 sh.80,303
BDXRay Dalio 2014-06-30 Sold Out $111.18 - $120.33
($116.18)
$ 117.171%Sold Out0
BDXMichael Price 2014-06-30 Reduce-0.57%$111.18 - $120.33
($116.18)
$ 117.171%Reduce -22.86%135,000
BDXRay Dalio 2014-03-31 Reduce$105.4 - $116.81
($112.54)
$ 117.174%Reduce -30.27%2,995
BDXMichael Price 2014-03-31 Reduce-0.36%$105.4 - $116.81
($112.54)
$ 117.174%Reduce -12.5%175,000
BDXYacktman Focused Fund 2014-03-31 Reduce-0.26%$105.4 - $116.81
($112.45)
$ 117.174%Reduce -32.84%450,000
BDXDonald Yacktman 2014-03-31 Reduce-0.2%$105.4 - $116.81
($112.45)
$ 117.174%Reduce -25.8%1,300,476
BDXJohn Hussman 2014-03-31 Reduce-0.2%$105.4 - $116.81
($112.45)
$ 117.174%Reduce -20%100,000
BDXYacktman Fund 2014-03-31 Reduce-0.12%$105.4 - $116.81
($112.45)
$ 117.174%Reduce -15.38%660,000
BDXArnold Van Den Berg 2014-03-31 Sold Out -0.02%$105.4 - $116.81
($112.45)
$ 117.174%Sold Out0
BDXJohn Hussman 2013-12-31 Add0.2%$98.33 - $110.6
($106.28)
$ 117.1710%Add 25%125,000
BDXArnold Van Den Berg 2013-12-31 Buy 0.02%$98.33 - $110.6
($106.28)
$ 117.1710%New holding, 1815 sh.1,815
BDXRay Dalio 2013-12-31 Reduce$98.33 - $110.6
($106.28)
$ 117.1710%Reduce -47.83%4,295
BDXJoel Greenblatt 2013-12-31 Sold Out -0.01%$98.33 - $110.6
($106.28)
$ 117.1710%Sold Out0
BDXRay Dalio 2013-09-30 Reduce$97.14 - $104.5
($100.36)
$ 117.1717%Reduce -34.32%8,232
BDXJoel Greenblatt 2013-09-30 Reduce-0.07%$97.14 - $104.5
($100.36)
$ 117.1717%Reduce -80.99%3,877
BDXRay Dalio 2013-06-30 Buy 0.01%$93.58 - $101.92
($97.74)
$ 117.1720%New holding, 12533 sh.12,533
BDXMichael Price 2013-06-30 Reduce-0.53%$93.58 - $101.92
($97.74)
$ 117.1720%Reduce -17.53%200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BDX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BDX Jean-Marie Eveillard 2014-06-30582,6560.30.17New Buy
BDX Joel Greenblatt 2014-06-3080,3030.040.12New Buy
BDX John Hussman 2014-06-30175,0000.091.6+75%
BDX Donald Yacktman 2014-06-301,304,2280.680.63+0.29%
BDX Ruane Cunniff 2014-06-302,27200
BDX Yacktman Fund 2014-06-30660,0000.340.67
BDX Yacktman Focused Fund 2014-06-30450,0000.230.54
BDX Dodge & Cox 2014-06-3016,7800.010-0.59%
BDX Mario Gabelli 2014-06-30544,8320.280.34-1.07%
BDX Vanguard Health Care Fund 2014-06-302,393,1001.240.75-6.94%
BDX Michael Price 2014-06-30135,0000.072-22.86%
BDX Ray Dalio 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


BDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sichak StephenSenior Vice President 2014-06-12Sell1,456$118.25-1.5view
COHEN GARY MExecutive Vice President 2014-06-10Sell12,476$119.24-2.31view
SHERMAN JEFFREY SSr. VP and General Counsel 2014-06-09Sell7,877$120.24-3.13view
KOZY WILLIAM AExecutive Vice President 2014-06-05Sell7,092$117.98-1.27view
SHERMAN JEFFREY SSr. VP and General Counsel 2014-03-06Sell1,303$115.161.15view
Sichak StephenSenior Vice President 2013-12-16Sell344$105.8210.07view
KOZY WILLIAM AExecutive Vice President 2013-11-12Sell9,597$108.37.55view
Hurwitz Jerome VSenior Vice President 2013-11-11Sell1,151$107.788.07view
SHERMAN JEFFREY SSr. VP and General Counsel 2013-11-11Sell4,272$107.788.07view
FORLENZA VINCENT AChairman, CEO and President 2013-11-08Sell32,411$107.398.46view

Press Releases about BDX :

    Quarterly/Annual Reports about BDX:

    News about bdx:

    Articles On GuruFocus.com
    Critical Investor John Hussman's Top Five Q2 Holdings Aug 01 2014 
    Top Three Holdings with Promising Outlook Jul 15 2014 
    Becton, Dickinson and Co. (BDX) Dividend Stock Analysis May 30 2014 
    CR Bard Focuses on Small to Medium-Sized Deals Apr 04 2014 
    Weekly 52-Week Highs Highlight: SRCL, BDX, LINTB, NI Jan 20 2014 
    3 Top Yielding Dividend Aristocrats with Low Dividend Payouts Oct 09 2013 
    Five Dividend Stocks Buying Back Their Own Shares Aug 23 2013 
    For a Healthier Portfolio - Look Here Jul 25 2013 
    Becton, Dickinson and Co. (BDX) Dividend Stock Analysis Jun 07 2013 
    comment on BDX May 12 2013 


    More From Other Websites
    BD - Together with Direct Relief and the National Association of Community Health Centers - Announce... Aug 25 2014
    BD - Together with Direct Relief and the National Association of Community Health Centers - Announce... Aug 25 2014
    BECTON DICKINSON & CO Financials Aug 09 2014
    BD AutoShield™ Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes Aug 06 2014
    BD AutoShield™ Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes Aug 06 2014
    BECTON DICKINSON & CO Files SEC form 10-Q, Quarterly Report Aug 04 2014
    BD Expands its Suite of Open System Solutions on the Fully Automated BD MAX™ Platform Aug 04 2014
    Critical Investor John Hussman's Top Five Q2 Holdings Aug 01 2014
    Wall Street Transcript Interview with Terrance H. Gregg, the CEO of Dexcom, Inc. (DXCM) Aug 01 2014
    UPDATE: Deutsche Bank Reiterates On Becton, Dickinson and Co. On Relative Valuation Aug 01 2014
    Becton, Dickinson Q3 Earnings Meet, Revenues Top Estimates Jul 31 2014
    Becton Dickinson and Co Earnings Call scheduled for 8:00 am ET today Jul 31 2014
    [$$] Becton Dickinson Profit Beats Expectations Jul 31 2014
    Q3 2014 Becton Dickinson and Co Earnings Release - Before Market Open Jul 31 2014
    BD Announces Results for 2014 Third Fiscal Quarter Jul 31 2014
    BECTON DICKINSON & CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 31 2014
    BD Announces Results For 2014 Third Fiscal Quarter Jul 31 2014
    Will Becton, Dickinson (BDX) Surprise This Earnings Season? Jul 30 2014
    New Chlamydia and Gonorrhea Assays on the BD Viper™ LT System Receive FDA 510k Clearance Jul 28 2014
    New Chlamydia and Gonorrhea Assays on the BD Viper™ LT System Receive FDA 510k Clearance Jul 28 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK